Estrella Immunopharma, Inc.
United States of America
Develops T-cell therapies for cancer treatment.
Advances CD19 and CD22 targeting chimeric antigen receptor T-cell therapies.
5858 Horton Street, Suite 370, Emeryville, CA 94608, United States
会社名
Group
親会社
子会社
得意先
仕入先
業務提携
銀行等
株主等
2026-07-11 13:06 (Model: api_private )
